It’s no secret that Alzheimer’s drugs aren’t working in clinical trials—potential drugs to treat the disease have a 99.6 percent failure rate. But, according…
While there is currently no treatment for Alzheimer’s disease, a drug called Aricept can temporarily ease the symptoms for a short period of time….
Nursing homes in the U.S. are inappropriately prescribing antipsychotic drugs to an estimated 179,000 patients per week, according to a 157-page report by the…
Another Alzheimer’s drug has failed in a phase 3 trial, the stage right before drugs go to the Food and Drug Administration for approval….
Scientists have finally cracked the code of how an experimental new drug called J147, which has a proven track record of reversing Alzheimer’s disease…
It hasn’t been a good week for Alzheimer’s drug development. Pfizer, one of the world’s biggest pharmaceutical companies, announced that they would abandon the…
Pfizer, one of the world’s largest pharmaceutical companies, has decided to halt any further development of Alzheimer’s and Parkinson’s drugs, the company announced on…
Sign up for a weekly digest of the latest research on Alzheimer’s and brain health.
Follow us